Operating expenses were $ 287.0 million, compared to $ 262.6 million for the same period in the prior year, primarily reflecting increased investment in the commercialization of VIVITROL and ARISTADA. (cnbc.com)
This compared to GAAP net loss of $ 68.9 million, or a basic and diluted GAAP net loss per share of $ 0.45 for the same period in the prior year. (cnbc.com)
System - wide sales growth refers to the percentage change in sales at all franchise and company - owned restaurants in one period from the same period in the prior year. (cnbc.com)